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Abstract
Background: Many of researchers have focused on the emerging pathogen, Norovirus, since its first identification
as the causing agent of nonbacterial acute gastroenteritis in humans. One of the virulence factors of norovirus, the
great genetic diversity attributed to point mutations and recombinations, has brought forth the result of significant
changes in the circulating norovirus genotype patterns.
Findings: In recognition of the necessity for tracking and monitoring of genetic diversity, a norovirus variant
among the most prevalent genotype GII-4, Norovirus Hu/GII-4/CUK-3/2008/KR (CUK-3), was isolated from stool
samples and analyzed on the level of whole genome sequence. Whole genome sequence analysis revealed three
ORF composites of the whole genome, ORF1 (5100 bp), ORF2 (1623 bp), and ORF3 (807 bp). Each genetic
relationship of CUK-3 variant analysis located the ORF1 (5,100 bp) in Cluster I, ORF2 (1623 bp) in Cluster I (2006b),
ORF3 (807 bp) in Cluster I, and the whole genome sequence (about 5.1 kb) in Cluster I in the phylogenetic tree.
And the phylogenetic analyses showed the same location of CUK-3 strain with the GII-4/2006b cluster in the
phylogenetic tree.
Conclusions: In This study, a first concerning the full-length sequence of a NoV variant in South Korea is
meaningful in that it can be used not only as a full-length NoV variant sequence standard for future comparison
studies, but also as useful material for the public health field by enabling the diagnosis, vaccine development, and
prediction of new emerging variants.
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Findings
Noroviruses (NoVs) are the most important viruses that
cause nonbacterial acute gastroenteritis in humans. In
addition to increased susceptibility, the elderly are at
increased risk for more severe disease and death, as are
the very young and the immunocompromised [1,2].
They are small, and non-enveloped viruses which and
belong to the family Caliciviridae, genus Norovirus.
Noroviruses have a single positive-strand NoV RNA
genome of about 7.6 kb in size. Three open reading
frames (ORFs) have been identified in the NoV gen-
omes. ORF1 encodes a polyprotein that is cleaved into
six non-structural (NS) proteins, which carry amino acid
sequence motifs conserved in NTPase, protease and
RNA-dependent RNA polymerase (RdRp) [3,4]. ORF2
encodes a major structural protein, Viral Protein (VP1),
which consist of two domains-the shell domain (S) and
the protruding arm (P) that is again divided into two
subdomains, P1 and P2. The S domain is highly con-
served while the P domain is variable. P2 of the P
domain is hypervariable and carries immune and cellular
recognition sites [5-7]. ORF3 encodes minor capsid pro-
tein, VP2, which is rich in basic amino acids and is pro-
posed to have a role in viral stability [8,9]
Recently, NoVs were recognized as novel emergent
pathogens. The main route of transmission is suspected
to be person-to-person, but food and water-borne
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transmission is also important [1,10,11]. According to
nucleotide sequence analysis of the capsid regions, noro-
viruses are classified into five genogroups, GI to GV,
each of which can be further divided into several clus-
ters or genotypes [12]. Among the five genogroups,
three genogroups (GI, GII and GIV) are known to cause
clinical illness in humans, and genotype GII-4 has been
the predominant circulating strain to the present [13].
The error-prone RNA replication and recombination
between viruses is what drives noroviruses to its the
great diversity. Furthermore, the accumulated mutations
of the hypervariable P2 domain of the VP1 protein pro-
duced different GII-4 NoVs [14]. The most representa-
tive of the resulting variant GII-4 strain, GII-4/2006b,
with 3 nucleotide insertions in the P2 domain at posi-
tion 6265, emerged in the summer of 2002 which lead
to a major gastroenteritis outbreak as well as an epi-
demic gastroenteritis worldwide in the winter of 2002/
2003 [15,16]. In South Korea, gastroenteritis outbreaks
by GII-4/2006b variants have been reported from Sep-
tember of 2007 to July of 2008 had been reported [17].
In this paper, the whole genome sequence of another
isolated variant of the emerging strain type, the GII-4
variant, was analyzed and compared with other variants
to reveal the genetic relationship and to predict the ten-
dency of GII-4 variants in South Korea.
NoV positive-stool sample was isolated from patients
with acute gastroenteritis in Daejeon, South Korea in
November 2008. The sample was obtained from the
Waterborne Virus Bank (Seoul, Korea). The stool sample
was stored at -70°. The viral genomic RNA was extracted
from 140 μl of 10% fecal suspension with the QIAamp®
Viral RNA Mini kit (Qiagen, Hilden, Germany) in accor-
dance with the manufacturer’s instructions.
For the detection of NoV, reverse transcription PCR
(RT-PCR) was performed with the One Step RT-PCR
kit (Qiagen, Hilden, Germany) with primers based on
the sequence of the norovirus capsid region (Table 1).
To analyze the whole genome sequence of the
detected norovirus strain, reverse transcription PCR
(RT-PCR) was performed with the One Step RT-PCR
kit (Qiagen, Hilden, Germany) with 10 pairs of newly
designed primer sets (Table 1). Ten fragments were
amplified; eight fragments for ORF1, one fragment for
ORF2, and one fragment for ORF3. The PCR products
were then analyzed by electrophoresis on 1.5% agarose
gel and ethidium bromide staining. The amplified frag-
ments were purified with HiYield™ Gel/PCR DNA
Extraction kit (RBC, Taipei, Taiwan) from the gel. Then,
the products were cloned into the pGEM-T Easy vector
(Promega, USA) and were sequenced by Genotech (Dae-
jeon, South Korea).
Sequence data analysis of the composite sequence of
ten plasmids aligned with Clustal W method using the
DNAStar software (DNAStar Inc.) revealed that the
whole genome was composed of three ORFs, 5100 bp
(ORF1), 1623 bp (ORF2), and 807 bp (ORF3).
The dendrograms were constructed with the neighbor-
joining method. The nucleotide sequence data reported
in this study have been deposited into GenBank (acces-
sion number; FJ514242).
A comparison of the nucleotide and amino acid
sequences of the entire ORF2 with reference strains
showed that CUK-3 strain had the highest sequence
similarity to the NoV GII-4 reference strain X76717.
The nucleotide similarity with CUK-3 was 60.1 - 88.0%
with the reference strains. A protein database search
(BLASTX) for the product of ORF2 yielded 59.3 - 92.0%
similarity. However, the cut-off value for amino acid
similarity between the CUK-3 variant and the GII-4
reference strains showed low identity (92.0%) for the
genomic sequences (Table 2).
To analyze the genetic relationship between the CUK-
3 variant and the other variants reported worldwide, the
sequences of ORF sequences and the whole genome
were processed with multiple sequence alignment. Each
analysis of CUK-3 located the ORF1 (5,100 bp) in Clus-
ter I, ORF2 (1623 bp) in Cluster I (2006b), and ORF3
(807 bp) in Cluster I as well as the whole genome
sequence (about 5.1 kb) in Cluster I (Figure 1).
As shown on the case analysis of ORF1, Cluster I con-
tains Hiroshoma1, Kumamoto1, Saga1, Hokkaodo1,
Aomori4, Miayagi5, Akita1, Aichi3 and showed the
highest similarity range (98.0~98.9%) (Figure 1A).
As shown on the case analysis of ORF2, Cluster I
(2006b) contains emerged the GII-4 varints in Japan and
showed the highest similarity range (97.7 - 99.0%),
whereas Cluster II (2006a) showed low similarity range
(91.7 - 92.3%) (Figure 1B).
As shown on the case analysis of ORF3, Cluster I
showed the highest similarity range (97.9 - 99.3%). Inter-
estingly, 02/03 group contains emerged the GII-4
vaiants in Europe showed more higher similarity range
(93.1 - 93.6%) than Cluster II contains emerged the GII-
4 variants in Japan (Figure 1C).
As shown on the case analysis of full length, the CUK-
3 strain showed the highest similarity (98.3%) with the
2006 epidemic strain, Aichi3/2006/JP strain, whereas
Ehime/5-30/2005/JP strain and Lordsdale/1993/UK
strain showed the lowest similarity (89.2%) (Figure 1D).
The CUK-3 strain can be placed on the same branch
of the phylogenetic tree as the GII-4/2006b cluster,
based on the nucleotide sequence of the RdRp region
and the amino acid sequence of the capsid protein (data
not shown). Also, the analysis of the GDD motif
(AANNTG) of the RdRp region of the GII-4 variants
reported worldwide indicated that the GDD motif of
CUK-3 strain was similar to that of the GII-4 variants of
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the epidemic strains in 2006. These strains were com-
mon in Hong Kong, Japan, and other regions of North
East Asia during the same period [12,18]. Such similari-
ties in analyses between CUK-3 and GII-4/2006b strain
are evidence of the reemergence of GII-4 variant.
In Europe and Asia, most norovirus outbreaks that
occurred after 2002 have been caused by GII-4 variant
strains (Figure 2). In addition, biennial emergences of
pandemic NoV GII-4 variants have been reported in
2002, 2004, 2006 and 2008 [12,18,19]. These GII-4 var-
iants have also been identified in South Korea and are
rapidly spreading worldwide.
Amino acid sequences of the capsid region encoded by
ORF2 was compared with a total of 39 GII-4 variants
reported from various countries including US, UK, Japan,
China, Germany etc. Date of 540 amino acid analyses
showed the pattern of changes of two amino acid in first
P1 domain, aa238 (S GII-4- >2002® T GII-4- <2002), aa250 (Y
GII-4- >2002 ® F GII-4- <2002). The P2 domain showed
five substitutions of amino acids, aa280 (A GII-4- >2002 ®
P GII-4- <2002), aa346 (A GII-4- >2002 ® P GII-4- <2002), aa367
(F GII-4- >1995 ® Y GII-4- >2002 ® F GII-4- <2002), aa376
(Q GII-4- >2002 ® E GII-4- <2002), and aa394 (G or S GII-4-
>2006® TGII-4- <2006). In addition, the second P1 domain
Table 1 Primer sets used in this study
Primer Sequence (5’® 3’) Polarity Regiona
Diagnosis primer sets GIF1M CTG CCC GAA TTY GTA AAT GAT GAT + 5342-5365
GIRIM CCA ACC CAR CCA TTR TAC ATY TG - 5649-5671
GIIF1M GGG AGG GCG ATC GCA ATC T + 5049-5067
GIIRIM CCR CCI GCA TRI CCR TTR TAC AT - 5367-5389
Designed primer sets ORF1-1F GTG AAT GAA GAT GGC GTC TAA C + 1-22
ORF1-1R AGT TCC ACT GCA AGG TCC TCA G - 999-1020
ORF1-2F CTG AGG ACC TTG CAG TGG AAC T + 999-1020
ORF1-2R ATG AGG GAA CCA GTG GTG AGA GT - 2018-2040
ORF1-3F CGT GCT CGA GGC GCA TCG ATT T + 1821-1842
ORF1-3R TTG TAC TCA TCA TAC TCT TCA - 2701-2721
ORF1-4F CAT TGC TCG AGC ATC AGG GCT AC + 2038-2060
ORF1-4R TTG ACT ATC CTC GAC CAG ATG CT - 3038-3060
ORF1-5F AGC ATC TGG TCG AGG ATA GTC AA + 3038-3060
ORF1-5R GTG GCA CAT ATG ACA GTG TTT CC - 3518-3540
ORF1-6F GGA AAC ACT GTC ATA TGT GCC AC + 3518-3540
ORF1-6R CAG TCG TTC TTC CGC ATG TGG TGC GG - 3935-3960
ORF1-7F CTC AGC ACC AAG ACT AAA TTC TGG A + 3635-3659
ORF1-7R TGG GCG ATG GAA TTC CAT TGA GAG G - 4485-4509
ORF1-8F ATG GTT AAA TTC TCC CCA GAA CC + 4355-4377
ORF1-8R CCA CCT GCA TAA CCA TTG TAC AT - 5367-5389
ORF2-F ATG AAG ATG GCG TCG AAT GGC + 5085-5105
ORF2-R TTA TAA TGC ACG CCT GCG CCC CGT - 6681-6704
ORF3-F ATG GCT GGA GCT TTC TTT GCT + 6704-6724
ORF3-R AAA GAC ACT AAA GAA AGG AAA GAT - 7532-7555
a Each of sequence number of primer sets region is indicated with Lordsdale strain (X86557) except that of GIF1M and GIR1M set indicated with Norwalk strains
(M87661).
Table 2 Nucleotide and amino acid sequence similarities
between CUK-3 strain and the full length ORF2 sequences
from different Genogroup GII reference strains
Genotype Strain Acession No. Similarity (%)
GII-1 H awaii-USA94 U07611 64.9a 64.6b
GII-2 Msham-GBR95 X81879 62.8 63.9
GII-3 Toronto-CAN93 U02030 64.8 67.4
GII-4 Bristol-GBR-93 X76716 88.0 92.0
GII-5 Hilingd-GBR00 AJ277607 64.6 63.9
GII-6 Seacrof-GBR00 AJ277620 63.0 63.9
GII-7 Leeds-GBR00 AJ277608 64.3 64.8
GII-8 Amstdam-NLD99 AF195848 64.3 64.8
GII-9 VABeach-USA01 AY038599 63.7 63.5
GII-10 Eufurt-DEU01 AF421118 63.5 64.8
GII-11 SW918-JPN01 AB074893 62.3 64.6
GII-12 Wortley-GBR00 AJ277618 63.3 63.9
GII-13 Faytvil-USA02 AY113106 64.5 64.3
GII-14 M7-USA03 AY130761 64.3 64.8
GII-15 J23-USA02 AY130762 60.1 59.3
GII-16 Tiffin-USA03 AY502010 64.1 65.9
GII-17 CSE1-USA03 AY502009 63.7 65.2
a The nucleotide sequences of the ORF2 regions starting at nucleotide 1620
were analyzed.
b The amino acid sequences of the ORF2 regions starting at amino acid 540
were analyzed.
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Figure 1 Phylogenetic trees of the nucleotide sequences of the complete regions of NoV GII/4. Phylogenetic tree generated based on
the complete sequence of the ORF1 (about 5.1 kb) (A), ORF2 (about 1.6 kb) (B), ORF3 (about 0.8 kb) (C), and near-full-length genome (7.5 kb) (D)
Figure 2 Partial sequence comparison of the RdRp gene. The boxed sequence is the conserved GDD motif, ANNNTG. Nucleotide positions
are referenced to the Lordsdale-1993-UK sequence.
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also showed two amino acid substitutions, aa459 (L GII-4-
>1995 ® Q GII-4- >2002) and aa504 (P GII-4- >2002 ® Q GII-4-
<2002). These analytic data showed that there had already
been numerous mutations, which lead to the production
of a wide range of variants, already before 2002 and pro-
duced various variants. And as shown on the case of aa394
of P2 domain which inserted novel amino acid, G or S,
and then substituted to T after 2006 (data not shown).
Although previous studies have indicated that the
sequence for the NoV capsid region is useful for the diag-
nosis of NoV variants, no studies have analyzed the RdRp
region of the South Korean NoV GII-4 variant. This is the
first report that describes the full-length sequence of a
NoV GII-4 variant that was isolated from clinical samples
in South Korea. We suggest that this sequence can be
used as a standard for the comparison of full-length NoV
GII-4 variant sequence with other strains.
The information acquired from whole genome
sequencing in this study can be useful not only for a
more accurate diagnoses of NoVs but also for the basic
research for the elucidation genetic functions. Further-
more, it will be helpful for the prediction of newly
appearing pandemic variants through comparison with
GII-4 variants in neighboring countries, fundamental
research for vaccine development, and eventually , for
the field of public health through with the provision of
new emerging strains of NoV.
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